Logo

IHC

Gastric Cancer Chemotherapy Response, Prognoses Predicted With Blood-Based Immune Proteomics

By analyzing blood serum proteomics alongside gastric tumors' omics profiles, researchers found immune features coinciding with treatment response and survival.

NeoGenomics, ImmunoGen Ink Testing Deal for Newly Approved Folate Receptor Drug

The pharma firm will cover the cost for eligible ovarian cancer patients to be tested using the companion diagnostic to its new drug Elahere.

Immunotherapy Response Features Identified in Pancreatic Cancer Microenvironment

Researchers compared tumor microenvironment features in pancreatic ductal adenocarcinoma cases receiving an allogeneic vaccine with or without anti-PD-1 treatment.

Cofactor Genomics RNA-seq Assay Outperforms PD-L1 IHC to Predict Immunotherapy Responders
Premium

The firm is aiming to commercialize its OncoPrism assay in 2023 as a laboratory-developed test to identify head and neck cancer patients eligible for checkpoint inhibitors.

Repeat Biomarker Testing Informs Next Steps for Treatment-Resistant EGFR-Mutant NSCLC Patients
Premium

Studies at ESMO showed the importance of repeat biomarker testing to guide treatment after resistance to AstraZeneca's Tagrisso, but tissue-based testing remains a hindrance. 

Aug 8, 2022

CAP Weighs in on dMMR, MSI Assays for Immunotherapy Patient Selection
Premium

Jul 12, 2022

NCCN Publishes First Guidelines for Pediatric Brain Cancer, Recommends Broad NGS Profiling

Jun 9, 2022

Tempus, Lilly Ink Partnership to Offer No-Cost NGS for Advanced NSCLC Patients

Apr 19, 2022

Breast Cancer Clues Revealed by Recurrent Tumor Microenvironment Structures

Dec 23, 2021

Multiomic Profiling Uncovers Predictors of Melanoma Response to Immunotherapy

Aug 20, 2021

Labcorp, CCORN Ink Partnership to Address Precision Oncology Disparities

Jun 4, 2021

Akoya Biosciences, AstraZeneca Collaborate on Spatial Biomarker Profiling for Immuno-Oncology

Jan 26, 2021

Researchers ID Four Small Cell Lung Cancer Subtypes, Suggest Future Treatment Implications
Premium

Dec 2, 2020

Diaceutics, Alva10 Gathering Evidence Base for Improving PD-L1 Test Reimbursement
Premium

Nov 18, 2020

Indivumed, Ultivue Sign Deal to Integrate Cancer Tissue Analysis Technologies

Nov 13, 2020

FDA Approves Merck's Keytruda, Agilent CDx in PD-L1-High Triple-Negative Breast Cancer

Sep 20, 2020

HPV, p16 May Offer Different Prognostic Clues in Oropharyngeal Cancer, ESMO Data Reveals
Premium

Jul 22, 2020

Ultivue, OracleBio Collaborate on Tissue Biomarker Analysis Workflow

May 29, 2020

Tumor Microbiome Appears to Vary With Cancer Type

Feb 25, 2020

10x Genomics Unveils 2020 New Product Pipeline at AGBT
Premium

Feb 19, 2020

10x Genomics Previews New Product Lineup Ahead of AGBT
Premium

Nov 5, 2019

Discovery Life Sciences Acquires QualTek Molecular Laboratories

Oct 31, 2019

HER2 Amplification Confers Drug Sensitivity Across Tumor Types in New Study
Premium

Sep 30, 2019

Tempus Finds Tumor-Normal Sequencing, RNA Profiling Aid Patient Matching to Therapies, Trials

Aug 8, 2019

Researchers Propose Role For Microbes in Pancreatic Cancer Immune Features, Survival

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.